Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Novel Tool to Improve Shared Decision Making and Adherence in Multiple Sclerosis: Development and Preliminary Testing.
Col N, Alvarez E, Springmann V, Ionete C, Berrios Morales I, Solomon A, Kutz C, Griffin C, Tierman B, Livingston T, Patel M, van Leeuwen D, Ngo L, Pbert L. Col N, et al. Among authors: ionete c. MDM Policy Pract. 2019 Oct 16;4(2):2381468319879134. doi: 10.1177/2381468319879134. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31667351 Free PMC article.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, Bar-Or A. Shinoda K, et al. Among authors: ionete c. Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2207291120. doi: 10.1073/pnas.2207291120. Epub 2023 Jan 12. Proc Natl Acad Sci U S A. 2023. PMID: 36634138 Free PMC article.
Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results.
Wilken J, Traboulsee A, Nelson F, Ionete C, Kolind S, Fratto T, Kane R, Gandhi R, Rawlings AM, Roesch N, Ozog MA, DeLuca J; LEM-COG investigators. Wilken J, et al. Among authors: ionete c. Mult Scler Relat Disord. 2023 May;73:104677. doi: 10.1016/j.msard.2023.104677. Epub 2023 Mar 27. Mult Scler Relat Disord. 2023. PMID: 37028124 Free article.
Multi-omics analysis of magnetically levitated plasma biomolecules.
Ashkarran AA, Gharibi H, Zeki DA, Radu I, Khalighinejad F, Keyhanian K, Abrahamsson CK, Ionete C, Saei AA, Mahmoudi M. Ashkarran AA, et al. Among authors: ionete c. Biosens Bioelectron. 2023 Jan 15;220:114862. doi: 10.1016/j.bios.2022.114862. Epub 2022 Nov 3. Biosens Bioelectron. 2023. PMID: 36403493 Free PMC article.
The varieties of psychosis in multiple sclerosis: A systematic review of cases.
Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. Camara-Lemarroy CR, et al. Among authors: ionete c. Mult Scler Relat Disord. 2017 Feb;12:9-14. doi: 10.1016/j.msard.2016.12.012. Epub 2016 Dec 23. Mult Scler Relat Disord. 2017. PMID: 28283114 Review.
Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals.
Col NF, Solomon AJ, Springmann V, Garbin CP, Ionete C, Pbert L, Alvarez E, Tierman B, Hopson A, Kutz C, Berrios Morales I, Griffin C, Phillips G, Ngo LH. Col NF, et al. Among authors: ionete c. Med Decis Making. 2018 Jan;38(1):44-55. doi: 10.1177/0272989X17724434. Epub 2017 Aug 14. Med Decis Making. 2018. PMID: 28806143 Free PMC article.
Evaluation of a Novel Preference Assessment Tool for Patients with Multiple Sclerosis.
Col NF, Solomon AJ, Springmann V, Ionete C, Alvarez E, Tierman B, Kutz C, Morales IB, Griffin C, Ngo LH, Jones DE, Phillips G, Hopson A, Pbert L. Col NF, et al. Among authors: ionete c. Int J MS Care. 2018 Nov-Dec;20(6):260-267. doi: 10.7224/1537-2073.2017-021. Int J MS Care. 2018. PMID: 30568563 Free PMC article.
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
Maghzi AH, Houtchens MK, Preziosa P, Ionete C, Beretich BD, Stankiewicz JM, Tauhid S, Cabot A, Berriosmorales I, Schwartz THW, Sloane JA, Freedman MS, Filippi M, Weiner HL, Bakshi R. Maghzi AH, et al. Among authors: ionete c. J Neurol. 2020 Oct;267(10):2790-2796. doi: 10.1007/s00415-020-09944-8. Epub 2020 Jun 3. J Neurol. 2020. PMID: 32494856 Free PMC article.
47 results